INTRODUCTION
Obesity is accompanied by low-grade chronic systemic inflammation, characterized by increased circulating levels of proinflammatory cytokines including interleukin (IL)-1β, tumor necrosis factor-α (TNF-α) and IL-6 (1). Activation of inflammatory pathways induces metabolic disturbances, leading to insulin resistance, dyslipidemia and cardiovascular diseases. Caspase-1 is a cysteine protease that is known for its crucial role in the activation of the pro-inflammatory cytokines IL-18 and IL-1β. Additionally, caspase-1 has been shown to cleave other substrates, including proteins involved in energy metabolism (2) (3) (4) . Caspase-1 activation is controlled by the inflammasome, a multiprotein complex consisting of a member of the Nod-like receptor family (e.g. NLRP3), and the inflammasome adaptor molecule ASC (5) . A close interaction has been described between the innate immune system and lipoprotein metabolism in general, and triglyceride (TG) metabolism in particular (6) . This interaction has largely been derived from studies that evaluated the effects of lipopolysaccharide (LPS), a major component of the cell wall of Gram-negative bacteria, and individual cytokines on lipoprotein metabolism (7) (8) (9) .
Although inflammasome-mediated caspase-1 activity has recently been linked to metabolic disturbances such as steatohepatitis (10) and cardiovascular diseases (11) , the role of caspase-1 in lipoprotein metabolism has never been elucidated. We recently showed that absence of caspase-1 in mice is accompanied by a profound decrease in both adipocyte size and total adipose tissue mass upon high-fat diet (HFD)-induced obesity (12) . Remarkably, inhibition of caspase-1 in adipocytes in vitro does not limit adipocyte differentiation (12) , suggesting that the decrease in adipose tissue mass in vivo is not due to a primary defect in adipogenesis, yet may be the result of a lack of sufficient lipid supply. An increased energy expenditure may at least partly explain the marked reduction in adipose tissue that was observed in caspase-1 deficient (caspase-1 -/-) (13). Besides energy expenditure, dietary intake and subsequent intestinal absorption of fat strongly contribute to the supply of lipids for storage in adipose tissue. Dietary fat is extremely efficiently absorbed in the by guest, on www.jlr.org Downloaded from 5 small intestine and incorporated into chylomicrons for distribution to other tissues. Interestingly, caspase-1 -/-mice fed a HFD display an increased feces weight (13) , suggesting a decreased intestinal capacity for the absorption of dietary fat. We therefore hypothesized that caspase-1 might play a direct role in the regulation of (postprandial) TG-rich lipoprotein metabolism that could contribute to the reduction in adipose tissue mass in caspase-1 -/-mice.
In the current study, we investigate the role of caspase-1 in TG metabolism and show that caspase-1 deficiency in mice markedly reduces intestinal TG absorption as well as hepatic very low-density lipoprotein (VLDL)-TG production, thereby limiting the availability of lipids for peripheral storage.
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To extract total cholesterol from feces, dried feces (10 mg) were incubated in 1 mL alkaline methanol (CH 3 OH: 1 M NaOH = 3:1 [vol/vol]) for 2 h at 80°C in screw-capped tubes using 5α-cholestane as internal standard. Tubes were cooled to room temperature and the cholesterol was extracted 2 times with 2 mL petroleum ether. The combined petroleum ether layers were evaporated to dryness, and the cholesterol was silylated by DMF-Silprep (Alltech). Analysis was performed by GC, using the 25 m×0.25 mm capillary GC column (CP Sil 5B, Chrompack
International) in a 3800 GC gas chromatograph (Varian) equipped with a flame ionization detector. Quantitation was based on the area ratio of the cholesterol to the internal standard 5α-cholestane. Phospholipid concentration was determined after lipid extraction using a commercially available enzymatic kit from Roche Molecular Biochemicals (Indianapolis, IN).
Postprandial TG response
To measure the postprandial response, overnight fasted mice received an intragastric load of 200 µL olive oil (Carbonell, Cordoba, Spain). Blood samples were drawn before (t=0) and 1, 2, 4 and 8 h after the bolus into chilled capillaries coated with paraoxon (Sigma, St Louis, MO) to prevent ongoing lipolysis (14) . Plasma was assayed for TG with the commercially available enzymatic kit from Roche Molecular Biochemicals (Indianapolis, IN) and for free FA (FFA) using NEFA-C kit from Wako Diagnostics (Instruchemie, Delfzijl, The Netherlands). 
In vivo clearance of TG-rich emulsion particles

Liver lipids
Lipids were extracted from livers of mice that were in a fed state and after 4h-fasting according to a modified protocol from Bligh and Dyer (18) . Briefly, a small piece of liver was homogenized in ice-cold methanol. After centrifugation, lipids were extracted by addition of 1800 µL Triton X-100. Hepatic TG, total cholesterol (TC) and phospholipid (PL) concentrations were measured using commercial kits from Roche Molecular Biochemicals (Indianapolis, IN). Liver lipids were expressed per mg protein, which was determined using the BCA protein assay kit.
RNA isolation and qPCR analysis
Total RNA was obtained from the epithelial layer of the duodenum, jejunum and ileum 2 h after an oral lipid bolus as well as from 4 h-fasted livers. RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA), followed by DNAse treatment and column purification using the RNeasy mini kit (Qiagen, Hilden, Germany). The RNA concentration was determined using a Nanodrop ND-1000 spectrophotometer and subsequent cDNA analysis was done using iScript reagent (Biorad). qPCR analysis was carried out on a Bio-Rad MyIQ. 36B4 was used as housekeeping genes and PCR primer sequences were taken from the PrimerBank and ordered by guest, on November 9, 2017 www.jlr.org
Downloaded from
from Eurogentec (Seraing, Belgium). Sequences of the primers used are available upon request.
Plasma β-hydroxybutyrate
Plasma β-hydroxybutyrate was measured in 4h fasted plasma samples using the beta-HB Assay Kit from Abcam (Cambridge, UK).
Western blot analysis
Tissues were homogenized by Ultraturrax (22,000 rpm; 2x5 sec) in an ice-cold buffer (pH 7. 
Statistical analysis
Data are presented as means ± SD. Statistical significant differences were calculated using a Student's T-test (SPSS Inc, Chicago, IL). P<0.05 was regarded statistically significant.
RESULTS
Absence of caspase-1 in mice reduces white adipose tissue mass
Caspase-1 -/-and wild-type (WT) mice were evaluated for body weight and adipose tissue mass.
In line with results from our previous study (12) , caspase-1 deficiency markedly reduced white adipose tissue (WAT) mass, while body weight was similar between caspase-1 -/-vs WT mice (30.0 ± 3.2 vs 30.8 ± 2.5 g). The reduction in WAT was reflected by a reduction in the amount of gWAT (-69%; P<0.001) and sWAT (-34%; P<0.01), and a trend toward reduction in the amount of vWAT (-17%; P=0.16). We have previously shown that caspase-1 deficient mice have 62%
increased bone mineral content (BMC), which likely explains why caspase-1 deficiency does not affect total body weight despite the reduced adipose tissue mass (12) . No difference was observed for total lean weight (-3%; P=0.51), liver weight (-7%; P=0.12) or muscle weight (-9%; P=0.27) between capase-1 -/-and WT mice.
Absence of caspase-1 in mice reduces the postprandial response to an oral lipid load
As intestinal absorption of fat strongly contributes to the supply of lipids for storage in adipose tissue, we investigated whether the reduction in adipose tissue mass and the resistance to obesity upon high fat feeding in caspase-1 -/-mice (12, 13) reflects impaired postprandial lipid handling. Hereto, overnight fasted WT and caspase-1 -/-mice received an intragastric olive oil bolus (200 µL) and the appearance of TG and FFA in plasma were determined (Fig 1) . Basal plasma TG levels were reduced in caspase-1 -/-mice compared to WT mice (0.53 ± 0.12 vs 0.82 ± 0.24 mM; P<0.01). Moreover in caspase-1 -/-mice, the postprandial increase in TG levels was markedly reduced (peak TG level -59% at t=2 h; P<0.01; Fig 1A) , which was paralleled by a postprandial drop in serum FFA levels (peak FFA level -38% at t=4 h; P<0.05; Fig 1B) .
Caspase-1 deficiency in mice does not affect TG-rich particle clearance
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The postprandial TG response is determined by the balance between intestinal TG production and the rate of plasma TG clearance. (Fig 2D) ,
indicating that TG-rich particle turnover was similar in caspase-1 -/-and WT mice. H-activity by tissues (Fig 3) . Two hours after the gavage, the appearance of 3 H activity in plasma of caspase-1 -/-mice was significantly reduced (-37%; P<0.001; Fig 3A) , suggesting a reduction in chylomicron-TG production. In line with this finding, a decreased amount of 13 deficiency reduces the intestinal TG absorption after an oral lipid load, and as a consequence reduces uptake and incorporation of intestinally derived TG into peripheral lipid stores.
To determine whether the reduced intestinal TG absorption resulted in an increased amount of lipids remaining within the intestinal tract, we isolated the intestinal tract 2 h after the gavage and determined both the amount of (Fig 3C) , suggesting sufficient intracellular lipid availability, which was confirmed by Oil red O staining (Suppl Fig S1) . Instead, caspase-1 deficiency resulted in the accumulation of non-absorbed [ wild-type mice (Fig 3E) , resulting in an increase of the total fecal FA content (85.7 ± 9.4 vs 69.4 ± 7.3 µmol/g feces; P<0.01; Fig 3F) . Caspase-1 deficiency specifically reduced the uptake of fatty acids, since fecal cholesterol and phospholipid levels were similar between caspase-1 -/-and WT mice (Suppl Fig S3) .
Caspase-1 deficiency in mice decreases VLDL-TG production, without affecting VLDLapoB production, despite increased hepatic lipid content.
In fasting conditions, the availability of lipids for peripheral organs is determined by the production of VLDL-TG by the liver through mechanisms similar to intestinal chylomicron by guest, on November 9, 2017 www.jlr.org
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synthesis. Since caspase-1 deficiency reduces postprandial chylomicron-TG production, we hypothesized that caspase-1 deficiency could similarly affect hepatic VLDL-TG production.
VLDL-TG production was measured in 4 h fasted mice by determining plasma TG levels after Triton WR1339 injection (Fig 4) . Caspase-1 -/-mice indeed showed a strong reduction of TG accumulation in plasma compared to WT mice (Fig 4A) . The VLDL-TG production rate, as determined from the slope of the curve from all individual mice, was decreased by -42% (3.6 ± 0.5 vs 6.3 ± 0.7 mM/h; P<0.001), whereas the rate of VLDL-apoB production did not change significantly ( Fig 4B) . As the reduced rate of VLDL-TG production could be caused by a decreased hepatic lipid substrate availability in the liver, we evaluated the hepatic TG ( Fig 4C) and TC ( Fig 4D) content in livers from both fed and 4 h-fasted WT and caspase-1 -/-mice. In the fed state, hepatic lipid content was not affected by caspase-1 deficiency. Surprisingly, 4 h of fasting strongly increased hepatic TG content in caspase-1 -/-compared to WT mice (+64%; P<0.05). This may be the result of an increased FA influx from the plasma, since plasma FFA levels were similarly increased after 4 h of fasting in caspase-1 -/-compared to WT mice. These data suggest that caspase-1 deficiency is associated with reduced hepatic VLDL-TG secretion despite adequate availability of lipids from both plasma and liver, suggesting a primary role of caspase-1 in the VLDL-TG secretion. In addition, the increased plasma FFA levels also exclude a reduction in lipolytic response of adipose tissue as the underlying cause of the reduction in VLDL-TG production. Caspase-1 deficiency is thus associated with a reduction of both intestinal chylomicron-TG-and hepatic VLDL-TG production, which may point towards a general role of caspase-1 in the assembly and/or secretion of TG-rich lipoprotein particles.
Caspase-1 deficiency in mice reduces hepatic and intestinal expression of genes involved in lipogenesis
The secretion of intestinal chylomicron-TG in the postprandial state and hepatic VLDL-TG in the fasted state are regulated by similar pathways (19 (Table 1) . Liver samples were collected after 4 h of fasting whereas intestinal samples were collected 2 h postprandial after an oral lipid load. Mice deficient for caspase-1 had normal expression levels of hepatic and intestinal apoB (Apob) and microsomal TG transfer protein (Mttp), both involved in the assembly and secretion of chylomicrons and VLDL. Also, hepatic protein levels of MTP were not affected by caspase-1 deficiency (Suppl Fig S4) .
Likewise, genes involved in FA oxidation including peroxisome proliferator activated receptor alpha (Ppara), PPAR-gamma coactivator 1-beta (Ppargc1b), carnitine palmitoyltransferase 1 (Cpt1) and mitochondrial carnitine/acylcarnitine translocase (Slc25A50)
were not changed in caspase-1 -/-mice. In line with this, caspase-1 deficiency did not affect plasma β-hydroxybutyrate levels (Suppl Fig S5) , suggesting no change in hepatic FA oxidation or ketogenesis. Genes involved in FA uptake, apart from an increased intestinal expression of It is interesting to speculate how caspase-1 deficiency reduces hepatic and intestinal TG secretion. The secretion of TG-rich lipoproteins is dependent on TG availability, which can be derived from FA supply from the diet (intestine), plasma (liver) or from de novo lipogenesis.
The reduction in intestinal TG secretion is not likely explained by a reduction in the uptake of FA, since caspase-1 deficiency did not reduce intestinal or hepatic expression of Cd36 and Slc27a4, proteins involved in FA transport. Actually, intestinal expression of Cd36 was increased in caspase-1 -/-mice. This may be a compensatory reaction to the reduced chylomicron secretion, since CD36 has shown to be essential for the production of chylomicrons (22) . Similar to the intestine, the reduction in hepatic TG secretion does not seem to be the result of a reduction in lipid uptake, based on the observation that plasma FFA levels are increased in caspase-1 -/-mice and hepatic genes involved in FA uptake are not changed.
It appears that caspase-1 deficiency is rather associated with reduced expression of the intestinal-and hepatic lipogenic genes such as Srebf1, Srebf2 and Fasn, which are involved in the FA synthesis and intracellular resynthesis of TG for the secretion of lipid-rich lipoproteins.
This could suggest that a reduction in de novo lipogenesis may underlie the reduced secretion of TG-rich lipoproteins in caspase-1 -/-mice. Within this scope, it is however surprising that the reduction in the de novo lipogenesis is not paralleled by a reduced intestinal and hepatic lipid content. Tracer studies and Oil Red O staining of intestinal sections revealed that enterocytes of both caspase-1 -/-and WT mice contained similar amount of lipids after an oral gavage of olive oil. Moreover, the hepatic TG levels were increased rather than reduced in caspase-1 -/-mice.
Within this context, the reduced expression of lipogenic genes that we observe may be a consequence rather than cause of the reduced TG secretion. Other studies indeed observed a reduction in Srebf1 as a response to steatosis (23) . Alternatively, the reduction in expression of genes involved in de novo lipogenesis may be the result of reduced plasma insulin levels in that are able to activate inflammasome-mediated caspase-1 (27) (28) (29) . In addition, accumulating evidence show that dietary nutrients can activate inflammatory pathways in the intestine (30) .
Hence, intestinal caspase-1 could be directly activated by lipids and other nutrients in the diet. intestinal and/or hepatic TG production, rather than by reduced LPL activity, which has been suggested as a possible mechanism for their observation (35) . An IL-1ß-mediated increase in intestinal TG secretion may also contribute to the tendency towards higher abdominal obesity previously observed in these subjects (36) . Similar to IL-1ß, genetic variation in IL-18 has been associated with postprandial TG levels (37) , suggesting that absence of caspase-1 may reduce TG-rich lipoprotein production indirectly via these cytokines. Future studies may verify whether our current observations are mediated via IL-1ß or IL-18. Interestingly, another possibility is that caspase-1 affects lipid metabolism independent of IL-1ß or IL-18, because in addition to IL-1ß
and IL-18, caspase-1 has been shown to be able to directly cleave additional substrates (2, 38) .
Remarkably, these substrates include several key metabolic proteins such as SIRT1 and PPARγ (3, 4) . It is reasonable to postulate that additional substrates of caspase-1 play regulatory roles in intracellular lipid metabolism. Future studies will therefore also need to identify new potential cleavage sites in proteins involved in intracellular FA transport and lipoprotein assembly that may contribute to the reduction in TG secretion in caspase-1 -/-mice.
In conclusion, we show that mice deficient for caspase-1 show an attenuated intestinal chylomicron-TG production and hepatic VLDL-TG production, both of which limit the availability of FA for uptake by adipose tissue. The current study reveals a novel function for caspase-1, or caspase-1-derived substrates, in controlling intestinal TG absorption and TG-rich lipoprotein assembly and secretion. We anticipate that caspase-1 may be a novel therapeutic target for the treatment of obesity and obesity-related disorders such as cardiovascular disease. Values are means ± SD. *P<0.05 and ***P<0.001. 
